Cellular function and pathological role of ATP13A2 and related P-type transport ATPases in Parkinson's disease and other neurological disorders

Frontiers in Molecular Neuroscience

Volumn 7, Issue MAY, 2014, Pages

  van Veen, Sarah ^a   Sørensen, Danny M ^a   Holemans, Tine ^a   Holen, Henrik W ^b   Palmgren, Michael G ^b   Vangheluwe, Peter ^a  

^a LABORATORY OF MOLECULAR AND CELLULAR SIGNALING   (Belgium)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Alpha synuclein; Dystonia; Flippase; Heavy metal toxicity; Lysosome; Mitochondria; Mitophagy; Parkinsonism

Indexed keywords

EID: 84901684788     PISSN: 16625099     EISSN: None     Source Type: Journal    
DOI: 10.3389/fnmol.2014.00048     Document Type: Review

References (172)

1. Albers, R. W. (1967). Biochemical aspects of active transport. Annu. Rev. Biochem. 36, 727-756. doi: 10.1146/annurev.bi.36.070167.003455
2. Ambrosini, A., D'Onofrio, M., Grieco, G. S., Di Mambro, A., Montagna, G., Fortini, D., et al. (2005). Familial basilar migraine associated with a new mutation in the ATP1A2 gene. Neurology 65, 1826-1828. doi: 10.1212/01.wnl.0000187072.71931.c0
3. Auluck, P. K., Caraveo, G., and Lindquist, S. (2010). alpha-Synuclein: membrane interactions and toxicity in Parkinson's disease. Annu. Rev. Cell Dev. Biol. 26, 211-233. doi: 10.1146/annurev.cellbio.042308.113313
4. Auranen, M., Vanhala, R., Varilo, T., Ayers, K., Kempas, E., Ylisaukko-Oja, T., et al. (2002). A genomewide screen for autism-spectrum disorders: evidence for a major susceptibility locus on chromosome 3q25-27. Am. J. Hum. Genet. 71, 777-790. doi: 10.1086/342720
5. Axelsen, K. B., and Palmgren, M. G. (1998). Evolution of substrate specificities in the P-type ATPase superfamily. J. Mol. Evol. 46, 84-101. doi: 10.1007/PL00006286
6. Ayala, A., Venero, J. L., Cano, J., and Machado, A. (2007). Mitochondrial toxins and neurodegenerative diseases. Front. Biosci. 12, 986-1007. doi: 10.2741/2119
7. Baldridge, R. D., and Graham, T. R. (2013). Two-gate mechanism for phospholipid selection and transport by type IV P-type ATPases. Proc. Natl. Acad. Sci. U.S.A. 110, E358-E367. doi: 10.1073/pnas.1216948110
8. Baldridge, R. D., Xu, P., and Graham, T. R. (2013). Type IV P-type ATPases distinguish mono-versus diacyl phosphatidylserine using a cytofacial exit gate in the membrane domain. J. Biol. Chem. 288, 19516-19527. doi: 10.1074/jbc.M113.476911
9. Benarroch, E. E. (2011). Na+, K+-ATPase: functions in the nervous system and involvement in neurologic disease. Neurology 76, 287-293. doi: 10.1212/WNL.0b013e3182074c2f
10. Bendor, J. T., Logan, T. P., and Edwards, R. H. (2013). The function of alpha-synuclein. Neuron 79, 1044-1066. doi: 10.1016/j.neuron.2013.09.004
11. Blanco-Arias, P., Einholm, A. P., Mamsa, H., Concheiro, C., Gutierrez-de-Teran, H., Romero, J., et al. (2009). A C-terminal mutation of ATP1A3 underscores the crucial role of sodium affinity in the pathophysiology of rapid-onset dystonia-parkinsonism. Hum. Mol. Genet. 18, 2370-2377. doi: 10.1093/hmg/ddp170
12. Bras, J., Verloes, A., Schneider, S. A., Mole, S. E., and Guerreiro, R. J. (2012). Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum. Mol. Genet. 21, 2646-2650. doi: 10.1093/hmg/dds089
13. Brashear, A., Ozelius, L. J., and Sweadner, K. J. (2014). ATP1A3 mutations: what is the phenotype? Neurology 82, 468-469. doi: 10.1212/WNL.0000000000000113
14. Bruggemann, N., Hagenah, J., Reetz, K., Schmidt, A., Kasten, M., Buchmann, I., et al. (2010). Recessively inherited parkinsonism: effect of ATP13A2 mutations on the clinical and neuroimaging phenotype. Arch. Neurol. 67, 1357-1363. doi: 10.1001/archneurol.2010.281
15. Bublitz, M., Morth, J. P., and Nissen, P. (2011). P-type ATPases at a glance. J. Cell Sci. 124, 2515-2519. doi: 10.1242/jcs.088716
16. Buch-Pedersen, M. J., Pedersen, B. P., Veierskov, B., Nissen, P., and Palmgren, M. G. (2009). Protons and how they are transported by proton pumps. Pflugers Arch. 457, 573-579. doi: 10.1007/s00424-008-0503-8
17. Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., and Cox, D. W. (1993). The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat. Genet. 5, 327-337. doi: 10.1038/ng1293-327
18. Burns, R. S., Chiueh, C. C., Markey, S. P., Ebert, M. H., Jacobowitz, D. M., and Kopin, I. J. (1983). A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. U.S.A. 80, 4546-4550. doi: 10.1073/pnas.80.14.4546
19. Burre, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., and Sudhof, T. C. (2010). Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro. Science 329, 1663-1667. doi: 10.1126/science.1195227
20. Chelly, J., Tumer, Z., Tonnesen, T., Petterson, A., Ishikawa-Brush, Y., Tommerup, N., et al. (1993). Isolation of a candidate gene for Menkes disease that encodes a potential heavy metal binding protein. Nat. Genet. 3, 14-19. doi: 10.1038/ng0193-14
21. Chesi, A., Kilaru, A., Fang, X., Cooper, A. A., and Gitler, A. D. (2012). The role of the Parkinson's disease gene PARK9 in essential cellular pathways and the manganese homeostasis network in yeast. PLoS ONE 7:e34178. doi: 10.1371/journal.pone.0034178
22. Chien, H. F., Bonifati, V., and Barbosa, E. R. (2011). ATP13A2-related neurodegeneration (PARK9) without evidence of brain iron accumulation. Mov. Disord. 26, 1364-1365. doi: 10.1002/mds.23514
23. Coleman, J. A., Vestergaard, A. L., Molday, R. S., Vilsen, B., and Andersen, J. P. (2012). Critical role of a transmembrane lysine in aminophospholipid transport by mammalian photoreceptor P4-ATPase ATP8A2. Proc. Natl. Acad. Sci. U.S.A. 109, 1449-1454. doi: 10.1073/pnas.1108862109
24. Cooper, A. A., Gitler, A. D., Cashikar, A., Haynes, C. M., Hill, K. J., Bhullar, B., et al. (2006). Alpha-synuclein blocks ER-Golgi traffic and Rab1 rescues neuron loss in Parkinson's models. Science 313, 324-328. doi: 10.1126/science.1129462
25. Corradi, G. R., de Tezanos Pinto, F., Mazzitelli, L. R., and Adamo, H. P. (2012). Shadows of an absent partner: ATP hydrolysis and phosphoenzyme turnover of the Spf1 (sensitivity to Pichia farinosa killer toxin) P5-ATPase. J. Biol. Chem. 287, 30477-30484. doi: 10.1074/jbc.M112.363465
26. Covy, J. P., Waxman, E. A., and Giasson, B. I. (2012). Characterization of cellular protective effects of ATP13A2/PARK9 expression and alterations resulting from pathogenic mutants. J. Neurosci. Res. 90, 2306-2316. doi: 10.1002/jnr.23112
27. 2+ homeostasis. J. Cell Biol. 157, 1017-1028. doi: 10.1083/jcb.200203052
28. Crosiers, D., Ceulemans, B., Meeus, B., Nuytemans, K., Pals, P., Van Broeckhoven, C., et al. (2011). Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation. Parkinsonism Relat. Disord. 17, 135-138. doi: 10.1016/j.parkreldis.2010.10.011
29. Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., and Sulzer, D. (2004). Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy. Science 305, 1292-1295. doi: 10.1126/science.1101738
30. Dastidar, R. G., Hooda, J., Shah, A., Cao, T. M., Henke, R. M., and Zhang, L. (2012). The nuclear localization of SWI/SNF proteins is subjected to oxygen regulation. Cell Biosci. 2, 30. doi: 10.1186/2045-3701-2-30
31. de Carvalho Aguiar, P., Sweadner, K. J., Penniston, J. T., Zaremba, J., Liu, L., Caton, M., et al. (2004). Mutations in the Na+/K+-ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism. Neuron 43, 169-175. doi: 10.1016/j.neuron.2004.06.028
32. De Fusco, M., Marconi, R., Silvestri, L., Atorino, L., Rampoldi, L., Morgante, L., et al. (2003). Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2. Nat. Genet. 33, 192-196. doi: 10.1038/ng1081
33. Dehay, B., Martinez-Vicente, M., Caldwell, G. A., Caldwell, K. A., Yue, Z., Cookson, M. R., et al. (2013). Lysosomal impairment in Parkinson's disease. Mov. Disord. 28, 725-732. doi: 10.1002/mds.25462
34. Dehay, B., Martinez-Vicente, M., Ramirez, A., Perier, C., Klein, C., Vila, M., et al. (2012a). Lysosomal dysfunction in Parkinson disease: ATP13A2 gets into the groove. Autophagy 8, 1389-1391. doi: 10.4161/auto.21011
35. Dehay, B., Ramirez, A., Martinez-Vicente, M., Perier, C., Canron, M. H., Doudnikoff, E., et al. (2012b). Loss of P-type ATPase ATP13A2/PARK9 function induces general lysosomal deficiency and leads to Parkinson disease neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 109, 9611-9616. doi: 10.1073/pnas.1112368109
36. De La Hera, D. P., Corradi, G. R., Adamo, H. P., and De Tezanos Pinto, F. (2013). Parkinson's disease-associated human P5B-ATPase ATP13A2 increases spermidine uptake. Biochem. J. 450, 47-53. doi: 10.1042/BJ20120739
37. Dereeper, A., Audic, S., Claverie, J. M., and Blanc, G. (2010). BLAST-EXPLORER helps you building datasets for phylogenetic analysis. BMC Evol. Biol. 10:8. doi: 10.1186/1471-2148-10-8
38. Dereeper, A., Guignon, V., Blanc, G., Audic, S., Buffet, S., Chevenet, F., et al. (2008). Phylogeny. fr: robust phylogenetic analysis for the non-specialist. Nucleic Acids Res. 36, W465-W469. doi: 10.1093/nar/gkn180
39. Devine, M. J., Plun-Favreau, H., and Wood, N. W. (2011). Parkinson's disease and cancer: two wars, one front. Nat. Rev. Cancer 11, 812-823. doi: 10.1038/nrc3150
40. DeWitt, M. R., Chen, P., and Aschner, M. (2013). Manganese efflux in Parkinsonism: insights from newly characterized SLC30A10 mutations. Biochem. Biophys. Res. Commun. 432, 1-4. doi: 10.1016/j.bbrc.2013.01.058
41. Di Fonzo, A., Chien, H. F., Socal, M., Giraudo, S., Tassorelli, C., Iliceto, G., et al. (2007). ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease. Neurology 68, 1557-1562. doi: 10.1212/01.wnl.0000260963.08711.08
42. Drin, G., and Antonny, B. (2010). Amphipathic helices and membrane curvature. FEBS Lett. 584, 1840-1847. doi: 10.1016/j.febslet.2009.10.022
43. Drin, G., Casella, J. F., Gautier, R., Boehmer, T., Schwartz, T. U., and Antonny, B. (2007). A general amphipathic alpha-helical motif for sensing membrane curvature. Nat. Struct. Mol. Biol. 14, 138-146. doi: 10.1038/nsmb1194
44. Ekberg, K., Palmgren, M. G., Veierskov, B., and Buch-Pedersen, M. J. (2010). A novel mechanism of P-type ATPase autoinhibition involving both termini of the protein. J. Biol. Chem. 285, 7344-7350. doi: 10.1074/jbc.M109.096123
45. Farias, F. H., Zeng, R., Johnson, G. S., Wininger, F. A., Taylor, J. F., Schnabel, R. D., et al. (2011). A truncating mutation in ATP13A2 is responsible for adult-onset neuronal ceroid lipofuscinosis in Tibetan terriers. Neurobiol. Dis. 42, 468-474. doi: 10.1016/j.nbd.2011.02.009
46. Ferguson, C. J., Lenk, G. M., and Meisler, M. H. (2009). Defective autophagy in neurons and astrocytes from mice deficient in PI(3,5)P2. Hum. Mol. Genet. 18, 4868-4878. doi: 10.1093/hmg/ddp460
47. Gautier, C. A., Corti, O., and Brice, A. (2014). Mitochondrial dysfunctions in Parkinson's disease. Rev. Neurol. (Paris) 170, 339-343. doi: 10.1016/j.neurol.2013.06.003
48. Geering, K. (2005). Function of FXYD proteins, regulators of Na, K-ATPase. J. Bioenerg. Biomembr. 37, 387-392. doi: 10.1007/s10863-005-9476-x
49. Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J., et al. (2009). Alpha-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308-315. doi: 10.1038/ng.300
50. Gordon, S. L., and Cousin, M. A. (2014). The Sybtraps: control of synaptobrevin traffic by synaptophysin, alpha-synuclein and AP-180. Traffic 15, 245-254. doi: 10.1111/tra.12140
51. Gourdon, P., Liu, X. Y., Skjorringe, T., Morth, J. P., Moller, L. B., Pedersen, B. P., et al. (2011). Crystal structure of a copper-transporting PIB-type ATPase. Nature 475, 59-64. doi: 10.1038/nature10191
52. Graham, T. R. (2004). Flippases and vesicle-mediated protein transport. Trends Cell Biol. 14, 670-677. doi: 10.1016/j.tcb.2004.10.008
53. Grunewald, A., Arns, B., Seibler, P., Rakovic, A., Munchau, A., Ramirez, A., et al. (2012). ATP13A2 mutations impair mitochondrial function in fibroblasts from patients with Kufor-Rakeb syndrome. Neurobiol. Aging 33, 1843. e1-1843. e7. doi: 10.1016/j.neurobiolaging.2011.12.035
54. Gupta, A., and Lutsenko, S. (2009). Human copper transporters: mechanism, role in human diseases and therapeutic potential. Future Med. Chem. 1, 1125-1142. doi: 10.4155/fmc.09.84
55. Gusdon, A. M., Zhu, J., Van Houten, B., and Chu, C. T. (2012). ATP13A2 regulates mitochondrial bioenergetics through macroautophagy. Neurobiol. Dis. 45, 962-972. doi: 10.1016/j.nbd.2011.12.015
56. Hall, P. A., and Russell, S. E. (2004). The pathobiology of the septin gene family. J. Pathol. 204, 489-505. doi: 10.1002/path.1654
57. Hamamichi, S., Rivas, R. N., Knight, A. L., Cao, S., Caldwell, K. A., and Caldwell, G. A. (2008). Hypothesis-based RNAi screening identifies neuroprotective genes in a Parkinson's disease model. Proc. Natl. Acad. Sci. U.S.A. 105, 728-733. doi: 10.1073/pnas.0711018105
58. Hasler, U., Crambert, G., Horisberger, J. D., and Geering, K. (2001). Structural and functional features of the transmembrane domain of the Na, K-ATPase beta subunit revealed by tryptophan scanning. J. Biol. Chem. 276, 16356-16364. doi: 10.1074/jbc.M008778200
59. Heinick, A., Urban, K., Roth, S., Spies, D., Nunes, F., Phanstiel, O., et al. (2010). Caenorhabditis elegans P5B-type ATPase CATP-5 operates in polyamine transport and is crucial for norspermidine-mediated suppression of RNA interference. FASEB J. 24, 206-217. doi: 10.1096/fj.09-135889
60. Heinzen, E. L., Swoboda, K. J., Hitomi, Y., Gurrieri, F., Nicole, S., de Vries, B., et al. (2012). De novo mutations in ATP1A3 cause alternating hemiplegia of childhood. Nat. Genet. 44, 1030-1034. doi: 10.1038/ng.2358
61. Hozumi, I., Hasegawa, T., Honda, A., Ozawa, K., Hayashi, Y., Hashimoto, K., et al. (2011). Patterns of levels of biological metals in CSF differ among neurodegenerative diseases. J. Neurol. Sci. 303, 95-99. doi: 10.1016/j.jns.2011.01.003
62. Jankovic, J. (2008). Parkinson's disease: clinical features and diagnosis. J. Neurol. Neurosurg. Psychiatr. 79, 368-376. doi: 10.1136/jnnp.2007.131045
63. Jensen, M. B., Bhatia, V. K., Jao, C. C., Rasmussen, J. E., Pedersen, S. L., Jensen, K. J., et al. (2011). Membrane curvature sensing by amphipathic helices: a single liposome study using alpha-synuclein and annexin B12. J. Biol. Chem. 286, 42603-42614. doi: 10.1074/jbc.M111.271130
64. Jin, S. M., and Youle, R. J. (2012). PINK1-and Parkin-mediated mitophagy at a glance. J. Cell Sci. 125, 795-799. doi: 10.1242/jcs.093849
65. Jurkat-Rott, K., Freilinger, T., Dreier, J. P., Herzog, J., Gobel, H., Petzold, G. C., et al. (2004). Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants. Neurology 62, 1857-1861. doi: 10.1212/01.WNL.0000127310.11526.FD
66. Kaler, S. G. (2011). ATP7A-related copper transport diseases-emerging concepts and future trends. Nat. Rev. Neurol. 7, 15-29. doi: 10.1038/nrneurol.2010.180
67. Kamp, F., Exner, N., Lutz, A. K., Wender, N., Hegermann, J., Brunner, B., et al. (2010). Inhibition of mitochondrial fusion by alpha-synuclein is rescued by PINK1, Parkin and DJ-1. EMBO J. 29, 3571-3589. doi: 10.1038/emboj.2010.223
68. Kanai, R., Ogawa, H., Vilsen, B., Cornelius, F., and Toyoshima, C. (2013). Crystal structure of a Na+-bound Na+, K+-ATPase preceding the E1P state. Nature 502, 201-206. doi: 10.1038/nature12578
69. Kennerson, M. L., Nicholson, G. A., Kaler, S. G., Kowalski, B., Mercer, J. F., Tang, J., et al. (2010). Missense mutations in the copper transporter gene ATP7A cause X-linked distal hereditary motor neuropathy. Am. J. Hum. Genet. 86, 343-352. doi: 10.1016/j.ajhg.2010.01.027
70. Kim, B. E., Smith, K., Meagher, C. K., and Petris, M. J. (2002). A conditional mutation affecting localization of the Menkes disease copper ATPase. Suppression by copper supplementation. J. Biol. Chem. 277, 44079-44084. doi: 10.1074/jbc.M208737200
71. Kim, B. E., Smith, K., and Petris, M. J. (2003). A copper treatable Menkes disease mutation associated with defective trafficking of a functional Menkes copper ATPase. J. Med. Genet. 40, 290-295. doi: 10.1136/jmg.40.4.290
72. Klein, C. (2014). Genetics in dystonia. Parkinsonism Relat. Disord. 20, S137-S142. doi: 10.1016/S1353-8020(13)70033-6
73. Kloet, S. L., Whiting, J. L., Gafken, P., Ranish, J., and Wang, E. H. (2012). Phosphorylation-dependent regulation of cyclin D1 and cyclin A gene transcription by TFIID subunits TAF1 and TAF7. Mol. Cell. Biol. 32, 3358-3369. doi: 10.1128/MCB.00416-12
74. Kong, S. M., Chan, B. K., Park, J. S., Hill, K. J., Aitken, J. B., Cottle, L., et al. (2014). Parkinson's disease linked human PARK9 / ATP13A2 maintains zinc homeostasis and promotes alphaSynuclein externalisation via exosomes. Hum. Mol. Genet. 23, 2816-2833. doi: 10.1093/hmg/ddu099
75. Kuhlbrandt, W. (2004). Biology, structure and mechanism of P-type ATPases. Nat. Rev. Mol. Cell Biol. 5, 282-295. doi: 10.1038/nrm1354
76. Kuwahara, T., Tonegawa, R., Ito, G., Mitani, S., and Iwatsubo, T. (2012). Phosphorylation of alpha-synuclein protein at Ser-129 reduces neuronal dysfunction by lowering its membrane binding property in Caenorhabditis elegans. J. Biol. Chem. 287, 7098-7109. doi: 10.1074/jbc.M111.237131
77. Kwasnicka-Crawford, D. A., Carson, A. R., Roberts, W., Summers, A. M., Rehnstrom, K., Jarvela, I., et al. (2005). Characterization of a novel cation transporter ATPase gene (ATP13A4) interrupted by 3q25-q29 inversion in an individual with language delay. Genomics 86, 182-194. doi: 10.1016/j.ygeno.2005.04.002
78. Lambie, E. J., Tieu, P. J., Lebedeva, N., Church, D. L., and Conradt, B. (2013). CATP-6, a C. elegans ortholog of ATP13A2 PARK9, positively regulates GEM-1, an SLC16A transporter. PLoS ONE 8:e77202. doi: 10.1371/journal.pone.0077202
79. Langston, J. W., and Ballard, P. A. Jr. (1983). Parkinson's disease in a chemist working with 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. N. Engl. J. Med. 309, 310. doi: 10.1056/NEJM198308043090511
80. Lees, A. J., Hardy, J., and Revesz, T. (2009). Parkinson's disease. Lancet 373, 2055-2066. doi: 10.1016/S0140-6736(09)60492-X
81. Lelong, E., Marchetti, A., Gueho, A., Lima, W. C., Sattler, N., Molmeret, M., et al. (2011). Role of magnesium and a phagosomal P-type ATPase in intracellular bacterial killing. Cell. Microbiol. 13, 246-258. doi: 10.1111/j.1462-5822.2010.01532.x
82. Lin, C. H., Tan, E. K., Chen, M. L., Tan, L. C., Lim, H. Q., Chen, G. S., et al. (2008). Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore. Neurology 71, 1727-1732. doi: 10.1212/01.wnl.0000335167.72412.68
83. Lohmann, K., and Klein, C. (2013). Genetics of dystonia: what's known? What's new? What's next? Mov. Disord. 28, 899-905. doi: 10.1002/mds.25536
84. Lopes da Fonseca, T., Correia, A., Hasselaar, W., van der Linde, H. C., Willemsen, R., and Outeiro, T. F. (2013). The zebrafish homologue of Parkinson's disease ATP13A2 is essential for embryonic survival. Brain Res. Bull. 90, 118-126. doi: 10.1016/j.brainresbull.2012.09.017
85. Machado, A., Chien, H. F., Deguti, M. M., Cancado, E., Azevedo, R. S., Scaff, M., et al. (2006). Neurological manifestations in Wilson's disease: report of 119 cases. Mov. Disord. 21, 2192-2196. doi: 10.1002/mds.21170
86. Mak, S. K., McCormack, A. L., Manning-Bog, A. B., Cuervo, A. M., and Di Monte, D. A. (2010). Lysosomal degradation of alpha-synuclein in vivo. J. Biol. Chem. 285, 13621-13629. doi: 10.1074/jbc.M109.074617
87. Makino, S., Kaji, R., Ando, S., Tomizawa, M., Yasuno, K., Goto, S., et al. (2007). Reduced neuron-specific expression of the TAF1 gene is associated with X-linked dystonia-parkinsonism. Am. J. Hum. Genet. 80, 393-406. doi: 10.1086/512129
88. Maroteaux, L., Campanelli, J. T., and Scheller, R. H. (1988). Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal. J. Neurosci. 8, 2804-2815.
89. Marshansky, V., and Futai, M. (2008). The V-type H+-ATPase in vesicular trafficking: targeting, regulation and function. Curr. Opin. Cell Biol. 20, 415-426. doi: 10.1016/j.ceb.2008.03.015
90. Meguro, M., Kashiwagi, A., Mitsuya, K., Nakao, M., Kondo, I., Saitoh, S., et al. (2001). A novel maternally expressed gene, ATP10C, encodes a putative aminophospholipid translocase associated with Angelman syndrome. Nat. Genet. 28, 19-20. doi: 10.1038/ng0501-19
91. Mercer, J. F., Livingston, J., Hall, B., Paynter, J. A., Begy, C., Chandrasekharappa, S., et al. (1993). Isolation of a partial candidate gene for Menkes disease by positional cloning. Nat. Genet. 3, 20-25. doi: 10.1038/ng0193-20
92. Middleton, E. R., and Rhoades, E. (2010). Effects of curvature and composition on alpha-synuclein binding to lipid vesicles. Biophys. J. 99, 2279-2288. doi: 10.1016/j.bpj.2010.07.056
93. Moller, A. B., Asp, T., Holm, P. B., and Palmgren, M. G. (2008). Phylogenetic analysis of P5 P-type ATPases, a eukaryotic lineage of secretory pathway pumps. Mol. Phylogenet. Evol. 46, 619-634. doi: 10.1016/j.ympev.2007.10.023
94. 2+-ATPase: design of a perfect chemi-osmotic pump. Q. Rev. Biophys. 43, 501-566. doi: 10.1017/S003358351000017X
95. Morth, J. P., Pedersen, B. P., Toustrup-Jensen, M. S., Sorensen, T. L., Petersen, J., Andersen, J. P., et al. (2007). Crystal structure of the sodium-potassium pump. Nature 450, 1043-1049. doi: 10.1038/nature06419
96. Najim al-Din, A. S., Wriekat, A., Mubaidin, A., Dasouki, M., and Hiari, M. (1994). Pallido-pyramidal degeneration, supranuclear upgaze paresis and dementia: Kufor-Rakeb syndrome. Acta Neurol. Scand. 89, 347-352. doi: 10.1111/j.1600-0404.1994.tb02645.x
97. Nebauer, R., Schuiki, I., Kulterer, B., Trajanoski, Z., and Daum, G. (2007). The phosphatidylethanolamine level of yeast mitochondria is affected by the mitochondrial components Oxa1p and Yme1p. FEBS J. 274, 6180-6190. doi: 10.1111/j.1742-4658.2007.06138.x
98. Newman, A. P., Shim, J., and Ferro-Novick, S. (1990). BET1, BOS1, and SEC22 are members of a group of interacting yeast genes required for transport from the endoplasmic reticulum to the Golgi complex. Mol. Cell. Biol. 10, 3405-3414.
99. Ning, Y. P., Kanai, K., Tomiyama, H., Li, Y., Funayama, M., Yoshino, H., et al. (2008). PARK9-linked parkinsonism in eastern Asia: mutation detection in ATP13A2 and clinical phenotype. Neurology 70, 1491-1493. doi: 10.1212/01.wnl.0000310427.72236.68
100. Nyblom, M., Poulsen, H., Gourdon, P., Reinhard, L., Andersson, M., Lindahl, E., et al. (2013). Crystal structure of Na+, K(+)-ATPase in the Na(+)-bound state. Science 342, 123-127. doi: 10.1126/science.1243352
101. Onat, O. E., Gulsuner, S., Bilguvar, K., Nazli Basak, A., Topaloglu, H., Tan, M., et al. (2013). Missense mutation in the ATPase, aminophospholipid transporter protein ATP8A2 is associated with cerebellar atrophy and quadrupedal locomotion. Eur. J. Hum. Genet. 21, 281-285. doi: 10.1038/ejhg.2012.170
102. Palmgren, M. G., and Nissen, P. (2011). P-type ATPases. Annu. Rev. Biophys. 40, 243-266. doi: 10.1146/annurev.biophys.093008.131331
103. Park, J. S., Koentjoro, B., Veivers, D., Mackay-Sim, A., and Sue, C. M. (2014). Parkinson's disease-associated human ATP13A2 (PARK9) deficiency causes zinc dyshomeostasis and mitochondrial dysfunction. Hum. Mol. Genet. 23, 2802-2815. doi: 10.1093/hmg/ddt623
104. Park, J. S., Mehta, P., Cooper, A. A., Veivers, D., Heimbach, A., Stiller, B., et al. (2011). Pathogenic effects of novel mutations in the P-type ATPase ATP13A2 (PARK9) causing Kufor-Rakeb syndrome, a form of early-onset parkinsonism. Hum. Mutat. 32, 956-964. doi: 10.1002/humu.21527
105. Paulsen, M., Lund, C., Akram, Z., Winther, J. R., Horn, N., and Moller, L. B. (2006). Evidence that translation reinitiation leads to a partially functional Menkes protein containing two copper-binding sites. Am. J. Hum. Genet. 79, 214-229. doi: 10.1086/505407
106. Pedersen, B. P., Buch-Pedersen, M. J., Morth, J. P., Palmgren, M. G., and Nissen, P. (2007). Crystal structure of the plasma membrane proton pump. Nature 450, 1111-1114. doi: 10.1038/nature06417
107. Petris, M. J., Camakaris, J., Greenough, M., LaFontaine, S., and Mercer, J. F. (1998). A C-terminal di-leucine is required for localization of the Menkes protein in the trans-Golgi network. Hum. Mol. Genet. 7, 2063-2071. doi: 10.1093/hmg/7.13.2063
108. Pinto Fde, T., Corradi, G. R., Hera, D. P., and Adamo, H. P. (2012). CHO cells expressing the human P(5)-ATPase ATP13A2 are more sensitive to the toxic effects of herbicide paraquat. Neurochem. Int. 60, 243-248. doi: 10.1016/j.neuint.2012.01.002
109. Podhajska, A., Musso, A., Trancikova, A., Stafa, K., Moser, R., Sonnay, S., et al. (2012). Common pathogenic effects of missense mutations in the P-type ATPase ATP13A2 (PARK9) associated with early-onset parkinsonism. PLoS ONE 7:e39942. doi: 10.1371/journal.pone.0039942
110. Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., et al. (1997). Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276, 2045-2047. doi: 10.1126/science.276.5321.2045
111. +-ATPase. Nature 467, 99-102. doi: 10.1038/nature09309
112. Poulsen, L. R., Lopez-Marques, R. L., and Palmgren, M. G. (2008). Flippases: still more questions than answers. Cell. Mol. Life Sci. 65, 3119-3125. doi: 10.1007/s00018-008-8341-6
113. Pranke, I. M., Morello, V., Bigay, J., Gibson, K., Verbavatz, J. M., Antonny, B., et al. (2011). alpha-Synuclein and ALPS motifs are membrane curvature sensors whose contrasting chemistry mediates selective vesicle binding. J. Cell Biol. 194, 89-103. doi: 10.1083/jcb.201011118
114. Quadri, M., Federico, A., Zhao, T., Breedveld, G. J., Battisti, C., Delnooz, C., et al. (2012). Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet. 90, 467-477. doi: 10.1016/j.ajhg.2012.01.017
115. Ramirez, A., Heimbach, A., Grundemann, J., Stiller, B., Hampshire, D., Cid, L. P., et al. (2006). Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat. Genet. 38, 1184-1191. doi: 10.1038/ng1884
116. Ramonet, D., Podhajska, A., Stafa, K., Sonnay, S., Trancikova, A., Tsika, E., et al. (2012). PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity. Hum. Mol. Genet. 21, 1725-1743. doi: 10.1093/hmg/ddr606
117. Remelli, M., Peana, M., Medici, S., Delogu, L. G., and Zoroddu, M. A. (2013). Interaction of divalent cations with peptide fragments from Parkinson's disease genes. Dalton Trans. 42, 5964-5974. doi: 10.1039/c2dt32222f
118. Rodacker, V., Toustrup-Jensen, M., and Vilsen, B. (2006). Mutations Phe785Leu and Thr618Met in Na+, K+-ATPase, associated with familial rapid-onset dystonia parkinsonism, interfere with Na+ interaction by distinct mechanisms. J. Biol. Chem. 281, 18539-18548. doi: 10.1074/jbc.M601780200
119. Rodriguez-Navarro, J. A., Kaushik, S., Koga, H., Dall'Armi, C., Shui, G., Wenk, M. R., et al. (2012). Inhibitory effect of dietary lipids on chaperone-mediated autophagy. Proc. Natl. Acad. Sci. U.S.A. 109, E705-E714. doi: 10.1073/pnas.1113036109
120. Rossi, G., Yu, J. A., Newman, A. P., and Ferro-Novick, S. (1991). Dependence of Ypt1 and Sec4 membrane attachment on Bet2. Nature 351, 158-161. doi: 10.1038/351158a0
121. Santoro, L., Breedveld, G. J., Manganelli, F., Iodice, R., Pisciotta, C., Nolano, M., et al. (2011). Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability. Neurogenetics 12, 33-39. doi: 10.1007/s10048-010-0259-0
122. Schack, V. R., Holm, R., and Vilsen, B. (2012). Inhibition of phosphorylation of na+, k+-ATPase by mutations causing familial hemiplegic migraine. J. Biol. Chem. 287, 2191-2202. doi: 10.1074/jbc.M111.323022
123. 2+ toxicity toSaccharomyces cerevisiae lacking YPK9p the orthologue of human ATP13A2. Biochem. Biophys. Res. Commun. 383, 198-202. doi: 10.1016/j.bbrc.2009.03.151
124. Schneider, S. A., Paisan-Ruiz, C., Quinn, N. P., Lees, A. J., Houlden, H., Hardy, J., et al. (2010). ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov. Disord. 25, 979-984. doi: 10.1002/mds.22947
125. Schultheis, P. J., Fleming, S. M., Clippinger, A. K., Lewis, J., Tsunemi, T., Giasson, B., et al. (2013). Atp13a2-Deficient mice exhibit neuronal ceroid lipofuscinosis, limited alpha-synuclein accumulation, and age-dependent sensorimotor deficits. Hum. Mol. Genet. 22, 2067-2082. doi: 10.1093/hmg/ddt057
126. Schultheis, P. J., Hagen, T. T., O'Toole, K. K., Tachibana, A., Burke, C. R., McGill, D. L., et al. (2004). Characterization of the P5 subfamily of P-type transport ATPases in mice. Biochem. Biophys. Res. Commun. 323, 731-738. doi: 10.1016/j.bbrc.2004.08.156
127. Sechi, G., Antonio Cocco, G., Errigo, A., Deiana, L., Rosati, G., Agnetti, V., et al. (2007). Three sisters with very-late-onset major depression and parkinsonism. Parkinsonism Relat. Disord. 13, 122-125. doi: 10.1016/j.parkreldis.2006.03.009
128. Sensi, S. L., Paoletti, P., Bush, A. I., and Sekler, I. (2009). Zinc in the physiology and pathology of the CNS. Nat. Rev. Neurosci. 10, 780-791. doi: 10.1038/nrn2734
129. Sepulveda, M. R., Wuytack, F., and Mata, A. M. (2012). High levels of Mn(2+) inhibit secretory pathway Ca(2+) /Mn(2+)-ATPase (SPCA) activity and cause Golgi fragmentation in neurons and glia. J. Neurochem. 123, 824-836. doi: 10.1111/j.1471-4159.2012.07888.x
130. Sheline, C. T., Zhu, J., Zhang, W., Shi, C., and Cai, A. L. (2013). Mitochondrial inhibitor models of Huntington's disease and Parkinson's disease induce zinc accumulation and are attenuated by inhibition of zinc neurotoxicity in vitro or in vivo. Neurodegener. Dis. 11, 49-58. doi: 10.1159/000336558
131. Shinoda, T., Ogawa, H., Cornelius, F., and Toyoshima, C. (2009). Crystal structure of the sodium-potassium pump at 2.4 A resolution. Nature 459, 446-450. doi: 10.1038/nature07939
132. Simonson, T., and Calimet, N. (2002). Cys(x)His(y)-Zn2+ interactions: thiol vs. thiolate coordination. Proteins 49, 37-48. doi: 10.1002/prot.10200
133. Sorensen, D. M., Buch-Pedersen, M. J., and Palmgren, M. G. (2010). Structural divergence between the two subgroups of P5 ATPases. Biochim. Biophys. Acta 1797, 846-855. doi: 10.1016/j.bbabio.2010.04.010
134. Sorensen, D. M., Moller, A. B., Jakobsen, M. K., Jensen, M. K., Vangheluwe, P., Buch-Pedersen, M. J., et al. (2012). Ca2+ induces spontaneous dephosphorylation of a novel P5A-type ATPase. J. Biol. Chem. 287, 28336-28348. doi: 10.1074/jbc.M112.387191
135. Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., and Goedert, M. (1997). Alpha-synuclein in lewy bodies. Nature 388, 839-840. doi: 10.1038/42166
136. Squitti, R., Polimanti, R., Bucossi, S., Ventriglia, M., Mariani, S., Manfellotto, D., et al. (2013). Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease. Rejuvenation Res. 16, 3-10. doi: 10.1089/rej.2012.1357
137. Swoboda, K. J., Kanavakis, E., Xaidara, A., Johnson, J. E., Leppert, M. F., Schlesinger-Massart, M. B., et al. (2004). Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation. Ann. Neurol. 55, 884-887. doi: 10.1002/ana.20134
138. Tan, J., Zhang, T., Jiang, L., Chi, J., Hu, D., Pan, Q., et al. (2011). Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 286, 29654-29662. doi: 10.1074/jbc.M111.233874
139. Tavassoli, S., Chao, J. T., Young, B. P., Cox, R. C., Prinz, W. A., de Kroon, A. I., et al. (2013). Plasma membrane-endoplasmic reticulum contact sites regulate phosphatidylcholine synthesis. EMBO Rep. 14, 434-440. doi: 10.1038/embor.2013.36
140. Telianidis, J., Hung, Y. H., Materia, S., and Fontaine, S. L. (2013). Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasis. Front. Aging Neurosci. 5:44. doi: 10.3389/fnagi.2013.00044
141. Tofaris, G. K. (2012). Lysosome-dependent pathways as a unifying theme in Parkinson's disease. Mov. Disord. 27, 1364-1369. doi: 10.1002/mds.25136
142. Tolleson, C. M., and Fang, J. Y. (2013). Advances in the mechanisms of Parkinson's disease. Discov. Med. 15, 61-66.
143. 2+-ATPase pumps ions across the sarcoplasmic reticulum membrane. Biochim. Biophys. Acta 1793, 941-946. doi: 10.1016/j.bbamcr.2008.10.008
144. Toyoshima, C., Nakasako, M., Nomura, H., and Ogawa, H. (2000). Crystal structure of the calcium pump of sarcoplasmic reticulum at 2.6 A resolution. Nature 405, 647-655. doi: 10.1038/35015017
145. 2+ dyshomeostasis caused by loss of ATP13A2/PARK9 leads to lysosomal dysfunction and alpha-synuclein accumulation. Hum. Mol. Genet. 23, 2791-2801. doi: 10.1093/hmg/ddt572
146. Tuschl, K., Clayton, P. T., Gospe, S. M. Jr., Gulab, S., Ibrahim, S., Singhi, P., et al. (2012). Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 90, 457-466. doi: 10.1016/j.ajhg.2012.01.018
147. Tuschl, K., Mills, P. B., and Clayton, P. T. (2013). Manganese and the brain. Int. Rev. Neurobiol. 110, 277-312. doi: 10.1016/B978-0-12-410502-7.00013-2
148. Ugolino, J., Fang, S., Kubisch, C., and Monteiro, M. J. (2011). Mutant Atp13a2 proteins involved in parkinsonism are degraded by ER-associated degradation and sensitize cells to ER-stress induced cell death. Hum. Mol. Genet. 20, 3565-3577. doi: 10.1093/hmg/ddr274
149. Usenovic, M., Knight, A. L., Ray, A., Wong, V., Brown, K. R., Caldwell, G. A., et al. (2012b). Identification of novel ATP13A2 interactors and their role in alpha-synuclein misfolding and toxicity. Hum. Mol. Genet. 21, 3785-3794. doi: 10.1093/hmg/dds206
150. Usenovic, M., Tresse, E., Mazzulli, J. R., Taylor, J. P., and Krainc, D. (2012a). Deficiency of ATP13A2 leads to lysosomal dysfunction, alpha-synuclein accumulation, and neurotoxicity. J. Neurosci. 32, 4240-4246. doi: 10.1523/JNEUROSCI.5575-11.2012
151. Vallipuram, J., Grenville, J., and Crawford, D. A. (2010). The E646D-ATP13A4 mutation associated with autism reveals a defect in calcium regulation. Cell. Mol. Neurobiol. 30, 233-246. doi: 10.1007/s10571-009-9445-8
152. 2+ pump. Proc. Natl. Acad. Sci. U.S.A. 106, 18533-18538. doi: 10.1073/pnas.0906797106
153. van der Mark, V. A., Elferink, R. P., and Paulusma, C. C. (2013). P4 ATPases: flippases in Health and Disease. Int. J. Mol. Sci. 14, 7897-7922. doi: 10.3390/ijms14047897
154. 2+ ATPase 2 (SERCA2) activity: cell biological implications. Cell Calcium 38, 291-302. doi: 10.1016/j.ceca.2005.06.033
155. 2+-transport ATPases. Chem. Rev. 109, 4733-4759. doi: 10.1021/cr900013m
156. Varkey, J., Isas, J. M., Mizuno, N., Jensen, M. B., Bhatia, V. K., Jao, C. C., et al. (2010). Membrane curvature induction and tubulation are common features of synucleins and apolipoproteins. J. Biol. Chem. 285, 32486-32493. doi: 10.1074/jbc.M110.139576
157. Vestergaard, A. L., Coleman, J. A., Lemmin, T., Mikkelsen, S. A., Molday, L. L., Vilsen, B., et al. (2014). Critical roles of isoleucine-364 and adjacent residues in a hydrophobic gate control of phospholipid transport by the mammalian P4-ATPase ATP8A2. Proc. Natl. Acad. Sci. U.S.A. 111, E1334-E1343. doi: 10.1073/pnas.1321165111
158. Vincenzi, F. F., Hinds, T. R., and Raess, B. U. (1980). Calmodulin and the plasma membrane calcium pump. Ann. N.Y. Acad. Sci. 356, 232-244. doi: 10.1111/j.1749-6632.1980.tb29614.x
159. Vulpe, C., Levinson, B., Whitney, S., Packman, S., and Gitschier, J. (1993). Isolation of a candidate gene for Menkes disease and evidence that it encodes a copper-transporting ATPase. Nat. Genet. 3, 7-13. doi: 10.1038/ng0193-7
160. Walker, S. S., Shen, W. C., Reese, J. C., Apone, L. M., and Green, M. R. (1997). Yeast TAF(II)145 required for transcription of G1/S cyclin genes and regulated by the cellular growth state. Cell 90, 607-614. doi: 10.1016/S0092-8674(00)80522-X
161. Wang, K., Jin, M., Liu, X., and Klionsky, D. J. (2013). Proteolytic processing of Atg32 by the mitochondrial i-AAA protease Yme1 regulates mitophagy. Autophagy 9, 1828-1836. doi: 10.4161/auto.26281
162. Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., and Rubinsztein, D. C. (2003). Alpha-Synuclein is degraded by both autophagy and the proteasome. J. Biol. Chem. 278, 25009-25013. doi: 10.1074/jbc.M300227200
163. Weingarten, L. S., Dave, H., Li, H., and Crawford, D. A. (2012). Developmental expression of P5 ATPase mRNA in the mouse. Cell. Mol. Biol. Lett. 17, 153-170. doi: 10.2478/s11658-011-0039-3
164. Williams, D. R., Hadeed, A., al-Din, A. S., Wreikat, A. L., and Lees, A. J. (2005). Kufor Rakeb disease: autosomal recessive, levodopa-responsive parkinsonism with pyramidal degeneration, supranuclear gaze palsy, and dementia. Mov. Disord. 20, 1264-1271. doi: 10.1002/mds.20511
165. Wohlke, A., Philipp, U., Bock, P., Beineke, A., Lichtner, P., Meitinger, T., et al. (2011). A one base pair deletion in the canine ATP13A2 gene causes exon skipping and late-onset neuronal ceroid lipofuscinosis in the Tibetan terrier. PLoS Genet. 7:e1002304. doi: 10.1371/journal.pgen.1002304
166. Worthey, E. A., Raca, G., Laffin, J. J., Wilk, B. M., Harris, J. M., Jakielski, K. J., et al. (2013). Whole-exome sequencing supports genetic heterogeneity in childhood apraxia of speech. J. Neurodev. Disord. 5, 29. doi: 10.1186/1866-1955-5-29
167. Xie, Z., and Xie, J. (2005). The Na/K-ATPase-mediated signal transduction as a target for new drug development. Front. Biosci. 10, 3100-3109. doi: 10.2741/1766
168. Xilouri, M., and Stefanis, L. (2011). Autophagic pathways in Parkinson disease and related disorders. Expert Rev. Mol. Med. 13, e8. doi: 10.1017/S1462399411001803
169. Xu, Q., Guo, H., Zhang, X., Tang, B., Cai, F., Zhou, W., et al. (2012). Hypoxia regulation of ATP13A2 (PARK9) gene transcription. J. Neurochem. doi: 10.1111/j.1471-4159.2012.07676.x
170. Zanni, G., Cali, T., Kalscheuer, V. M., Ottolini, D., Barresi, S., Lebrun, N., et al. (2012). Mutation of plasma membrane Ca2+ ATPase isoform 3 in a family with X-linked congenital cerebellar ataxia impairs Ca2+ homeostasis. Proc. Natl. Acad. Sci. U.S.A. 109, 14514-14519. doi: 10.1073/pnas.1207488109
171. Zhou, X., Sebastian, T. T., and Graham, T. R. (2013). Auto-inhibition of Drs2p, a yeast phospholipid flippase, by its carboxyl-terminal tail. J. Biol. Chem. 288, 31807-31815. doi: 10.1074/jbc.M113.481986
172. Zhu, X., Libby, R. T., de Vries, W. N., Smith, R. S., Wright, D. L., Bronson, R. T., et al. (2012). Mutations in a P-type ATPase gene cause axonal degeneration. PLoS Genet. 8:e1002853. doi: 10.1371/journal.pgen.1002853